Specimens such as serum, blood and tissue may hold the key to a better understanding the world`s diseases and improved drug discovery.
The Biobanking and Sample Management Strategies Conference 2012 is dedicated to strategies and best practices for collecting, cataloging, and storing specimens and samples crucial to drug discovery research, including
- Understanding the impact of global regulations
- Deciphering and following industry best practices from NIH and ISBER for sample storage and FDA regulations for biobanks and repositories
- Leverage data and automation tools to ensure specimens are properly cataloged and processed
- Adopting strategies to choose the best off-site vendor to store samples long-term
- The role of hospital and academic biobanks to further the research goal
- Ensure easy access to internal specimens being used for research or clinical trials
- Alternate forms of biobank models such as virtual biobanks
Who should Attend
Leaders from pharmaceutical and biotech companies.
